Biopharma IPOs: Timing, capital and staying flexible

The life sciences landscape is shifting quickly, and biopharma companies are being forced to operate differently than they did a few years ago. Regulatory shifts, tight capital and volatile IPO windows are reshaping biopharma strategy. Hear how leaders are adapting.

Source: FierceBiotech